Clinical and pharmacological group: & nbsp

Anticoagulants

Non-narcotic analgesics, including non-steroidal and other anti-inflammatory drugs

Regenerants and reparants

Included in the formulation
  • Hepatrombin
    ointment externally 
    Hemofarm AD     Serbia
  • Hepatrombin
    gel externally 
    Hemofarm AD     Serbia
  • Hepatrombin
    gel externally 
    Hemofarm AD     Serbia
  • Hepatrombin
    ointment externally 
    Hemofarm AD     Serbia
  • АТХ:

    C.05.B.A.53   Heparin in combination with other drugs

    C.05.B.A   Heparin-containing preparations for topical application

    Pharmacodynamics:

    Combination agent for topical application.

    Sodium Heparin

    Anticoagulant direct action. By activating antithrombin III accelerates its anticoagulant effect. It blocks the synthesis of thrombin, reduces the aggregation of platelets. Reduces the activity of hyaluronidase. Prevents formation and promotes resorption of existing thrombi, improves local blood flow, has anti-inflammatory and anti-edematous effect.

    Allantoin

    Promotes regeneration processes, enhances cell proliferation, improves metabolic processes in tissues.

    Dexpanthenol

    Accelerates the processes of tissue epithelization, helps accelerate the absorption of heparin.

    Pharmacokinetics:

    The drug for topical application, systemic action on the body does not.

    The half-life of the skin and epidermis is 1-1.5 hours.

    Indications:

    It is used for the treatment of vascular diseases of the lower extremities: thrombophlebitis, thrombosis, varicose veins. Used for sports injuries, inflammatory infiltrates, tendovaginitis.

    IX.I80-I89.I80   Phlebitis and thrombophlebitis

    IX.I80-I89.I83   Varicose veins

    IX.I80-I89.I83.2   Varicose veins of the lower extremities with ulcer and inflammation

    XIII.M65-M68.M65   Synovitis and tenosynovitis

    XIX.T08-T14.T14.0   Superficial injury of unspecified area of ​​the body

    XIX.T08-T14.T14   Injury of unspecified site

    Contraindications:Violation of the integrity of the skin, an individual intolerance, a child up to 3 years.

    Carefully:

    Thrombocytopenia, hypersensitivity.

    Pregnancy and lactation:

    Recommendations for FDA - Category B. It is used during pregnancy and lactation.

    Dosing and Administration:

    It is applied externally 2-3 times a day in a column of 4-5 cm, not rubbing, for 10-14 days.

    The highest daily dose: 15-20 cm.

    The highest single dose: 5 cm.

    Side effects:

    Allergic reactions.

    Overdose:

    Cases of overdose are not described.

    Treatment is symptomatic.

    Interaction:

    Clinically significant interactions are not described.

    Special instructions:

    When treating trophic ulcers ointment is applied in a column in the form of a ring with a width of up to 4 cm.

    With diseases of the veins, bandages with ointment are used.

    Instructions
    Up